11-62688043-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_203422.4(LRRN4CL):​c.466G>C​(p.Ala156Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

LRRN4CL
NM_203422.4 missense

Scores

1
8
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.211
Variant links:
Genes affected
LRRN4CL (HGNC:33724): (LRRN4 C-terminal like) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRN4CLNM_203422.4 linkc.466G>C p.Ala156Pro missense_variant Exon 2 of 2 ENST00000317449.5 NP_981967.1 Q8ND94

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRN4CLENST00000317449.5 linkc.466G>C p.Ala156Pro missense_variant Exon 2 of 2 1 NM_203422.4 ENSP00000325808.4 Q8ND94

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 26, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.466G>C (p.A156P) alteration is located in exon 2 (coding exon 1) of the LRRN4CL gene. This alteration results from a G to C substitution at nucleotide position 466, causing the alanine (A) at amino acid position 156 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Uncertain
0.058
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.20
T
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.39
FATHMM_MKL
Benign
0.062
N
LIST_S2
Benign
0.54
T
M_CAP
Uncertain
0.14
D
MetaRNN
Uncertain
0.59
D
MetaSVM
Benign
-0.87
T
MutationAssessor
Uncertain
2.8
M
PrimateAI
Uncertain
0.68
T
PROVEAN
Uncertain
-3.4
D
REVEL
Uncertain
0.31
Sift
Benign
0.048
D
Sift4G
Benign
0.12
T
Polyphen
0.98
D
Vest4
0.40
MutPred
0.67
Gain of disorder (P = 0.0872);
MVP
0.49
MPC
1.1
ClinPred
0.95
D
GERP RS
0.78
Varity_R
0.55
gMVP
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-62455515; API